Report overview
The global Multiparametric In-vitro Cardiotoxicity Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Calcium Transient Assay Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Multiparametric In-vitro Cardiotoxicity Testing include Creative Bioarray, Agilent Technologies, Inc., Hemogenix Inc., Merck KGaA, Molecular Devices, LLC., Miltenyi Biotec, FUJIFILM Cellular Dynamics, Enzo Life Sciences, Inc. and Axol Bioscience Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Multiparametric In-vitro Cardiotoxicity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiparametric In-vitro Cardiotoxicity Testing. This report contains market size and forecasts of Multiparametric In-vitro Cardiotoxicity Testing in global, including the following market information:
Global Multiparametric In-vitro Cardiotoxicity Testing Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Multiparametric In-vitro Cardiotoxicity Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiparametric In-vitro Cardiotoxicity Testing Market, by Type of Assay, 2020-2024, 2025-2030 ($ millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, by Type of Assay, 2023 (%)
Calcium Transient Assay
Cardiac Marker Detection
hERG Assay
Multi-ion Channel Assay
Others
Global Multiparametric In-vitro Cardiotoxicity Testing Market, by Application, 2020-2024, 2025-2030 ($ millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, by Application, 2023 (%)
Contract Research Organizations (CROs)
Pharmaceutical and Biotech Companies
Others
Global Multiparametric In-vitro Cardiotoxicity Testing Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions)
Global Multiparametric In-vitro Cardiotoxicity Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiparametric In-vitro Cardiotoxicity Testing revenues in global market, 2020-2024 (estimated), ($ millions)
Key companies Multiparametric In-vitro Cardiotoxicity Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Creative Bioarray
Agilent Technologies, Inc.
Hemogenix Inc.
Merck KGaA
Molecular Devices, LLC.
Miltenyi Biotec
FUJIFILM Cellular Dynamics
Enzo Life Sciences, Inc.
Axol Bioscience Ltd.
emka TECHNOLOGIES
Eurofins Discovery
Stemina Biomarker Discovery, Inc.
Evotec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiparametric In-vitro Cardiotoxicity Testing, market overview.
Chapter 2: Global Multiparametric In-vitro Cardiotoxicity Testing market size in revenue.
Chapter 3: Detailed analysis of Multiparametric In-vitro Cardiotoxicity Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type of assay, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiparametric In-vitro Cardiotoxicity Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
